The 76th American Association for Clinical Chemistry Annual Meeting and Clinical Laboratory Medicine Expo (ADLM, formerly AACC) will be held at McCormick Place, Chicago, USA from July 30 to August 1, 2024. Founded in 1949, ADLM is the highest quality and largest annual event in the field of clinical testing in the world. It is held in different cities in the United States every July and has great international influence. Last year, there were more than 900 exhibitors, displaying a large number of the latest world clinical laboratory testing technology equipment and in vitro diagnostic products in more than 2,500 booths, attracting more than 20,000 international medical professionals from 110 countries. 80% of the audience are leaders and decision makers with purchasing power. ADLM has become the main venue and communication platform for new product launches and seeking cooperation in the field of clinical testing.
VACURE will be making its debut at ADLM 2024 with its blockbuster products. We sincerely invite you to join us at ADLM, where you will gather with over 900 exhibitors from around the world to witness the world's latest medical industry event, explore VACURE's latest one-stop solution for multi-scenario clinical testing, and accelerate the company's internationalization process.
BOOTH INFORMATION
Booth number: 1165
Exhibition time: 30 July - 1 August, 2024
Exhibition location: McCormick Place, Chicago, U.S.A.
About VACURE
VACURE is a high-tech enterprise focusing on the field of in vitro agnostics (IVD) point-of-care testing (POCT). The company has brought together many R&D personnel (accounting for 39%) such as the Provincial Thousand Talents Plan.
Based on self-developed patented core technologies such as microfluidic chip design, time-resolved fluorescent nanomaterials, and inkjet freeze-drying, it has independently developed LYOFIA® strip microfluidic POCT system, a fluorescence immunoassay quantitative detection platform, iteratively upgraded the DISKFLU® Disc Panel Microfluidic POCT system, and deployed the GENFLU® Microfluidic Molecule POCT system to create POCT immune and molecular products with excellent performance, realizing the integration of raw materials, instruments and The entire chain of reagents is self-developed and produced. Since 2023, it has set sail overseas and its products have been exported to 100+ countries at home and abroad.
Send an email to book a meeting in advance!
Email: info@vacurebiotech.com
Tel：0086-028 85155537